Morphea After Bromocriptine Therapy
- 1 April 1989
- journal article
- case report
- Published by Wiley in International Journal of Dermatology
- Vol. 28 (3) , 177-179
- https://doi.org/10.1111/j.1365-4362.1989.tb02457.x
Abstract
A 57-year-old man developed morphea while taking bromocriptine. This drug is a semisynthetic ergot alkaloid, one of a class of drugs that is associated with fibrotic disorders. Other agents known for such association are serotonin (5-hydroxytryptamine) and beta-adrenergic blockers. A common pathogenesis to link these agents to fibrosis remains uncertain.Keywords
This publication has 16 references indexed in Scilit:
- Mediators of increased collagen synthesis in fibrosing organs*1Fundamental and Applied Toxicology, 1985
- Absence of Specific Binding of Several Putative Neuro-Transmitters to Human FibroblastsJournal of Receptor Research, 1983
- BROMOCRIPTINE INDUCED COLLAGENOSIS-LIKE SYMPTOMATOLOGY IN PARKINSON'S DISEASEThe Lancet, 1982
- Two types of alpha adrenoceptors in liver cellsTrends in Pharmacological Sciences, 1982
- Regulation of Collagen Production by the β-Adrenergic SystemJournal of Clinical Investigation, 1981
- Effects of vasoactive and inflammatory agents on cyclic AMP levels in W 138 fibroblasts, endothelial and vascular smooth muscle cells in cultureInflammation Research, 1980
- PEYRONIE'S DISEASE IN ASSOCIATION WITH METOPROLOLThe Lancet, 1977
- PROPRANOLOL AND PEYRONIE'S DISEASEThe Lancet, 1977
- PROPRANOLOL AND PEYRONIE'S DISEASEThe Lancet, 1977
- Untoward effects associated with practolol administration: oculomucocutaneous syndrome.BMJ, 1975